Eisai Farmacêutica S.A. clinical trials
A country office of Eisai Co., Ltd.
The registry lists 1 studies whose lead sponsor is Eisai Farmacêutica S.A.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 3, 2016.
Registry sponsor names on this page
- Eisai Farmacêutica S.A.1 study
Something wrong with this grouping? Tell us on the Eisai Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Eisai Co., Ltd. studies →
- Eribulin [Halaven] Use For the Treatment of Advanced Breast CancerCompletedNCT02790320
Sponsor listed in the registry: Eisai Farmacêutica S.A.